Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

Impact of Race/Ethnicity on Platelet Function

Completed

Conditions: Coronary Heart Disease

First Posted Date: 2010-07-23

Last Posted Date: 2023-09-01

Lead Sponsor: University of Nebraska

Target Recruit Count: 625

Registration Number: NCT01168622

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Maximizing Outcomes Needed After Percutaneous Coronary Intervention (PCI) Using Weight Management (MOMENTUM)

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: MOMENTUM

First Posted Date: 2010-07-16

Last Posted Date: 2023-09-29

Lead Sponsor: University of Nebraska

Target Recruit Count: 50

Registration Number: NCT01163968

Locations: 🇺🇸
BryanLGH Medical Center, Lincoln, Nebraska, United States

Periodontal Disease and P. Gingivalis in Rheumatoid Arthritis

Completed

Conditions: Rheumatoid Arthritis
Osteoarthritis
Periodontal Disease

Interventions: Radiation: Digital xray of jaw and teeth
Procedure: Blood draw
Other: questionnaires
Procedure: Periodontal Examination
Other: Bilateral digital xray of hands

First Posted Date: 2010-07-02

Last Posted Date: 2023-11-02

Lead Sponsor: University of Nebraska

Target Recruit Count: 617

Registration Number: NCT01156155

Locations: 🇺🇸
Veterans Affairs Medical Center, Omaha, Omaha, Nebraska, United States

Interventions to Decrease the Impact of Post-OPerative Ileus After Liver Transplant or Resection Surgery

Phase 1

Completed

Conditions: Ileus

Interventions: Drug: stool softener
Dietary Supplement: sugar free gum

First Posted Date: 2010-07-02

Last Posted Date: 2023-09-07

Lead Sponsor: University of Nebraska

Target Recruit Count: 111

Registration Number: NCT01156129

Locations: 🇺🇸
Unversity of Nebraska Medical Center, Omaha, Nebraska, United States

Herbal Lollipops on Oral Bacterial Levels and DMFT/Dmft Scores of Children With Asthma Using Inhalers

Not Applicable

Terminated

Conditions: Asthma
Dental Caries

Interventions: Dietary Supplement: Chinese Licorice Root

First Posted Date: 2010-06-22

Last Posted Date: 2023-08-23

Lead Sponsor: University of Nebraska

Target Recruit Count: 39

Registration Number: NCT01147835

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Aqueous Humor Dynamics and Brimonidine

Early Phase 1

Completed

Conditions: Intraocular Pressure

Interventions: Drug: Brimonidine
Drug: Artificial tears

First Posted Date: 2010-06-15

Last Posted Date: 2023-11-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 35

Registration Number: NCT01144494

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Cyclophosphamide and Paclitaxel With or Without Trastuzumab in Stage I-II Breast Cancer Who Have Undergone Surgery

Phase 2

Completed

Conditions: Stage IA Breast Cancer
Stage IB Breast Cancer
Stage IIA Breast Cancer
Stage IIB Breast Cancer

Interventions: Drug: cyclophosphamide
Drug: paclitaxel
Biological: trastuzumab
Other: laboratory biomarker analysis

First Posted Date: 2010-04-20

Last Posted Date: 2023-09-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 112

Registration Number: NCT01106898

Locations: 🇺🇸
Saint Francis Medical Center, Grand Island, Nebraska, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Lenalidomide and Cyclophosphamide in Treating Patients With Previously Treated Hormone-Refractory Prostate Cancer

Phase 1

Terminated

Conditions: Recurrent Prostate Cancer
Adenocarcinoma of the Prostate
Hormone-resistant Prostate Cancer

Interventions: Drug: lenalidomide
Drug: cyclophosphamide
Other: laboratory biomarker analysis
Other: questionnaire administration
Other: quality-of-life assessment

First Posted Date: 2010-03-25

Last Posted Date: 2023-09-13

Lead Sponsor: University of Nebraska

Target Recruit Count: 25

Registration Number: NCT01093183

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Phase 1

Completed

Conditions: Adenocarcinoma of the Pancreas
Stage III Pancreatic Cancer

Interventions: Drug: gemcitabine hydrochloride
Drug: leucovorin calcium
Drug: fluorouracil
Drug: nelfinavir mesylate
Radiation: stereotactic body radiation therapy
Radiation: hypofractionated radiation therapy
Procedure: therapeutic conventional surgery

First Posted Date: 2010-02-12

Last Posted Date: 2023-10-10

Lead Sponsor: University of Nebraska

Target Recruit Count: 46

Registration Number: NCT01068327

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Study of Lenalidomide and Ofatumumab for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 1

Completed

Conditions: Non-Hodgkin's Lymphoma

Interventions: Drug: Lenalidomide
Drug: ofatumumab

First Posted Date: 2010-02-02

Last Posted Date: 2023-10-04

Lead Sponsor: University of Nebraska

Target Recruit Count: 46

Registration Number: NCT01060384

Locations: 🇺🇸
Saint Francis Medical Center, Grand Island, Nebraska, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy